Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sara J. Dozier"'
Autor:
Jeffrey H. Hager, Nicholas D. Smith, Tadimeti S. Rao, Stewart A. Noble, Andrew K. Shiau, Jerry Muhammad, Robert L. Davis, James W. Malecha, Alan Saven, Brandon M. Wiley, Sara J. Dozier, Timothy Z. Hoffman, Elena L. Milkova, John V. Anzola, Yan Wang, Carol Trotter, Céline Bonnefous, David A. Jenkins, Joseph E. Payne, Paul L. Wash, Tami Annable, Phan-Manh Nguyen, Xin Guo, Kent T. Symons, Christian A. Hassig
Supplementary Fig. S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0239cd0b9e59719d73ad9a95a451c7a2
https://doi.org/10.1158/1535-7163.22485309
https://doi.org/10.1158/1535-7163.22485309
Autor:
Jeffrey H. Hager, Nicholas D. Smith, Tadimeti S. Rao, Stewart A. Noble, Andrew K. Shiau, Jerry Muhammad, Robert L. Davis, James W. Malecha, Alan Saven, Brandon M. Wiley, Sara J. Dozier, Timothy Z. Hoffman, Elena L. Milkova, John V. Anzola, Yan Wang, Carol Trotter, Céline Bonnefous, David A. Jenkins, Joseph E. Payne, Paul L. Wash, Tami Annable, Phan-Manh Nguyen, Xin Guo, Kent T. Symons, Christian A. Hassig
Supplementary Table S1 from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ad2d0b912497ade790e8191dc8a1a6a
https://doi.org/10.1158/1535-7163.22485300
https://doi.org/10.1158/1535-7163.22485300
Autor:
Jeffrey H. Hager, Nicholas D. Smith, Tadimeti S. Rao, Stewart A. Noble, Andrew K. Shiau, Jerry Muhammad, Robert L. Davis, James W. Malecha, Alan Saven, Brandon M. Wiley, Sara J. Dozier, Timothy Z. Hoffman, Elena L. Milkova, John V. Anzola, Yan Wang, Carol Trotter, Céline Bonnefous, David A. Jenkins, Joseph E. Payne, Paul L. Wash, Tami Annable, Phan-Manh Nguyen, Xin Guo, Kent T. Symons, Christian A. Hassig
Supplementary Methods from KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c14bc54c95af4c3db718bbfdaab0ab55
https://doi.org/10.1158/1535-7163.22485303.v1
https://doi.org/10.1158/1535-7163.22485303.v1
Autor:
Jeffrey H. Hager, Nicholas D. Smith, Tadimeti S. Rao, Stewart A. Noble, Andrew K. Shiau, Jerry Muhammad, Robert L. Davis, James W. Malecha, Alan Saven, Brandon M. Wiley, Sara J. Dozier, Timothy Z. Hoffman, Elena L. Milkova, John V. Anzola, Yan Wang, Carol Trotter, Céline Bonnefous, David A. Jenkins, Joseph E. Payne, Paul L. Wash, Tami Annable, Phan-Manh Nguyen, Xin Guo, Kent T. Symons, Christian A. Hassig
Histone deacetylase (HDAC) inhibitors have garnered significant attention as cancer drugs. These therapeutic agents have recently been clinically validated with the market approval of vorinostat (SAHA, Zolinza) for treatment of cutaneous T-cell lymph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1f183e54b1bbd2454f1a4fe5e3e9de
https://doi.org/10.1158/1535-7163.c.6531885.v1
https://doi.org/10.1158/1535-7163.c.6531885.v1
Autor:
Sara J. Dozier, Lynne Zummo
Publikováno v:
Journal of Geoscience Education. 70:530-545
Publikováno v:
Karolinska Institutet
Scopus-Elsevier
Scopus-Elsevier
Cells in a low oxygen, or hypoxic, microenvironment must have the ability to sense oxygen levels in the nucleus in order to maintain oxygen homeostasis by gene regulation. Hypoxia inducible factor-1 (HIF-1) serves as a molecular bridge between the se
Autor:
Timothy Z. Hoffman, Celine Bonnefous, Tadimeti S. Rao, Jerry Muhammad, James W. Malecha, Paul L. Wash, Christian A. Hassig, Nicholas D. Smith, Kent T. Symons, Xin Guo, John V. Anzola, Elena L. Milkova, Alan Saven, Tami Annable, Jeffrey H. Hager, Andrew K. Shiau, Stewart A. Noble, David A. Jenkins, Carol Trotter, Joseph E. Payne, Yan Wang, Phan-Manh Nguyen, Brandon M. Wiley, Sara J. Dozier, Robert L. Davis
Publikováno v:
Molecular cancer therapeutics. 7(5)
Histone deacetylase (HDAC) inhibitors have garnered significant attention as cancer drugs. These therapeutic agents have recently been clinically validated with the market approval of vorinostat (SAHA, Zolinza) for treatment of cutaneous T-cell lymph
Publikováno v:
Antioxidants & Redox Signaling; Aug2003, Vol. 5 Issue 4, p467, 7p